Developmental effects related to angiogenesis and osteogenic differentiation in Salmon larvae continuously exposed to dioxin-like 3,3',4,4'-tetrachlorobiphenyl (congener 77)

Aquatic Toxicology

Volumn 105, Issue 3-4, 2011, Pages 669-680

  Olufsen, Marianne ^a   Arukwe, Augustine ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

AhR; Angiogenesis; Development; Dioxin like PCB; Osteogenesis; Yolk sac larvae

Indexed keywords

3,3',4,4' TETRACHLOROBIPHENYL; ALIZARIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN TYPE 2; COLLAGEN TYPE 2 ALPHA 1; DYE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RED DYE; RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

DEVELOPMENTAL STAGE; DIOXIN; ESTROGENIC COMPOUND; LARVA; MORPHOGENESIS; PCB; POLLUTION EXPOSURE; RNA; SALMONID;

AHR GENE; ANEMIA; ANGIOGENESIS; ARTICLE; BMP2 GENE; BMP4 GENE; BONE DEVELOPMENT; BONE STRUCTURE; CARDIOVASCULAR SYSTEM; CHONDROGENESIS; COL2A1 GENE; CONTROLLED STUDY; DEVELOPMENTAL GENE; EGG; EMBRYO; ENVIRONMENTAL EXPOSURE; ER ALPHA GENE; ER BETA GENE; GENETIC TRANSCRIPTION; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART RATE; LARVAL DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RUNX2 GENE; SALMON; SOX9 GENE; TGF BETA GENE; VEGF GENE; YOLK SAC;

AGE FACTORS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; LARVA; METABOLIC DETOXICATION, DRUG; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; POLYCHLORINATED BIPHENYLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; SALMO SALAR; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; WATER POLLUTANTS, CHEMICAL;

EID: 80053458529     PISSN: 0166445X     EISSN: 18791514     Source Type: Journal    
DOI: 10.1016/j.aquatox.2011.09.005     Document Type: Article

References (95)

1. Abnet C.C., Tanguay R.L., Hahn M.E., Heideman W., Peterson R.E. Two forms of aryl hydrocarbon receptor type 2 in rainbow trout (Oncorhynchus mykiss). Evidence for differential expression and enhancer specificity. J. Biol. Chem. 1999, 274:15159-15166.
2. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002, 16:2813-2828.
3. Antkiewicz D.S., Peterson R.E., Heideman W. Blocking expression of AHR2 and ARNT1 in zebrafish larvae protects against cardiac toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 2006, 94:175-182.
4. Arukwe A. Toxicological housekeeping genes: do they really keep the house?. Environ. Sci. Technol. 2006, 40:7944-7949.
5. Arukwe A., Nordbø B. Hepatic biotransformation responses in Atlantic salmon exposed to retinoic acids and 3,3',4,4'-tetrachlorobiphenyl (PCB congener 77). Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2008, 147:470-482.
6. Balon, E.K., 1985. Microscopic techniques for studies of early ontogeny in fishes: problems and methods of composite descriptions. Early life histories of fishes: new developmental, ecological and evolutionary perspectives, pp. 33-35.
7. Belair C.D., Peterson R.E., Heideman W. Disruption of erythropoiesis by dioxin in the zebrafish. Dev. Dyn. 2001, 222:581-594.
8. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox9 is required for cartilage formation. Nat. Genet. 1999, 22:85-89.
9. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:6698-6703.
10. Bittinger M.A., Nguyen L.P., Bradfield C.A. Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor. Mol. Pharmacol. 2003, 64:550-556.
11. Bolognese M.A. SERMs and SERMs with estrogen for postmenopausal osteoporosis. Rev. Endocr. Metab. Disord. 2010, 4:253-259.
12. Bonventre J.A., White L.A., Cooper K.R. Methyl tert butyl ether targets developing vasculature in zebrafish (Danio rerio) embryos. Aquat. Toxicol. 2011, 105:29-40.
13. Breen E., Tang K., Olfert M., Knapp A., Wagner P. Skeletal muscle capillarity during hypoxia: VEGF and its activation. High Alt. Med. Biol. 2008, 9:158-166.
14. Carvalho P.S., Noltie D.B., Tillitt D.E. Intra-strain dioxin sensitivity and morphometric effects in swim-up rainbow trout (Oncorhynchus mykiss). Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2004, 137:133-142.
15. Chan W.K., Yao G., Gu Y.Z., Bradfield C.A. Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. J. Biol. Chem. 1999, 274:12115-12123.
16. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
17. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., Lowik C.W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002, 143:1545-1553.
18. Denicourt C., Dowdy S.F. Another twist in the transforming growth factor beta-induced cell-cycle arrest chronicle. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15290-15291.
19. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003, 43:309-334.
20. Dery M.A., Michaud M.D., Richard D.E. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol. 2005, 37:535-540.
21. Eames B.F., Sharpe P.T., Helms J.A. Hierarchy revealed in the specification of three skeletal fates by Sox9 and Runx2. Dev. Biol. 2004, 274:188-200.
22. Elonen G.E., Spehar R.L., Holcombe G.W., Johnson R.D., Fernandez J.D., Erickson R.J. Comparative toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to seven freshwater fish species during early life-stage development. Environ. Toxicol. Chem. 1998, 17:472-483.
23. Erlebacher A., Filvaroff E.H., Gitelman S.E., Derynck R. Toward a molecular understanding of skeletal development. Cell 1995, 80:371-378.
24. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., Nebert D.W., Rudikoff S., Ward J.M., Gonzalez F.J. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995, 268:722-726.
25. Filby A.L., Tyler C.R. Molecular characterization of estrogen receptors 1, 2α, and 2β and their tissue and ontogenic expression profiles in fathead minnow (Pimephales promelas). Biol. Reprod. 2005, 73:648-662.
26. Fleming C.R., Billiard S.M., Di Giulio R.T. Hypoxia inhibits induction of aryl hydrocarbon receptor activity in topminnow hepatocarcinoma cells in an ARNT-dependent manner. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2009, 150:383-389.
27. Glynn A.W., Michaelsson K., Lind P.M., Wolk A., Aune M., Atuma S., Darnerud P.O., Mallmin H. Organochlorines and bone mineral density in Swedish men from the general population. Osteoporos. Int. 2000, 11:1036-1042.
28. Gomez-Duran A., Carvajal-Gonzalez J.M., Mulero-Navarro S., Santiago-Josefat B., Puga A., Fernandez-Salguero P.M. Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling. Biochem. Pharmacol. 2009, 77:700-712.
29. Gonzalez F.J., Fernandez-Salguero P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab. Dispos. 1998, 26:1194-1198.
30. Gorodilov Y.N. Description of the early ontogeny of the Atlantic salmon, Salmo salar, with a novel system of interval (state) identification. Environ. Biol. Fish. 1996, 47:109-127.
31. Gradin K., McGuire J., Wenger R.H., Kvietikova I., Fhitelaw M.L., Toftgard R., Tora L., Gassmann M., Poellinger L. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 1996, 16:5221-5231.
32. Grasman K.A., Scanlon P.F., Fox G.A. Geographic variation in hematological variables in adult and prefledgling herring gulls (Larus argentatus) and possible associations with organochlorine exposure. Arch. Environ. Contam. Toxicol. 2000, 38:244-253.
33. Gu Y.Z., Hogenesch J.B., Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 2000, 40:519-561.
34. Guiney P.D., Smolowitz R.M., Peterson R.E., Stegeman J.J. Correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in vascular endothelium with toxicity in early life stages of lake trout. Toxicol. Appl. Pharmacol. 1997, 143:256-273.
35. Hahn M.E., Karchner S.I., Evans B.R., Franks D.G., Merson R.R., Lapseritis J.M. Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. J. Exp. Zool. A Comp. Exp. Biol. 2006, 305:693-706.
36. Halm S., Martinez-Rodriguez G., Rodriguez L., Prat F., Mylonas C.C., Carrillo M., Zanuy S. Cloning, characterisation, and expression of three oestrogen receptors (ERα, ERβ1 and ERβ2) in the European sea bass, Dicentrarchus labrax. Mol. Cell. Endocrinol. 2004, 223:63-75.
37. Hanno K., Oda S., Mitani H. Effects of dioxin isomers on induction of AhRs and CYP1A1 in early developmental stage embryos of medaka (Oryzias latipes). Chemosphere 2010, 78:830-839.
38. Hansson M.C., Wittzell H., Persson K., von Schantz T. Unprecedented genomic diversity of AhR1 and AhR2 genes in Atlantic salmon (Salmo salar L.). Aquat. Toxicol. 2004, 68:219-232.
39. Harada S.-I., Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 2003, 423:349-355.
40. Hornung M.W., Spitsbergen J.M., Peterson R.E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters cardiovascular and craniofacial development and function in sac fry of rainbow trout (Oncorhynchus mykiss). Toxicol. Sci. 1999, 47:40-51.
41. Horton W.A., Machado M.A., Ellard J., Campbell D., Bartley J., Ramirez F., Vitale E., Lee B. Characterization of a type II collagen gene (COL2A1) mutation identified in cultured chondrocytes from human hypochondrogenesis. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:4583-4587.
42. Ichihara S., Yamada Y., Gonzalez F.J., Nakajima T., Murohara T., Ichihara G. Inhibition of ischemia-induced angiogenesis by benzo[a]pyrene in a manner dependent on the aryl hydrocarbon receptor. Biochem. Biophys. Res. Commun. 2009, 381:44-49.
43. Ikuta T., Kobayashi Y., Kawajiri K. Phosphorylation of nuclear localization signal inhibits the ligand-dependent nuclear import of aryl hydrocarbon receptor. Biochem. Biophys. Res. Commun. 2004, 317:545-550.
44. Iuchi I., Yamamoto M. Erythropoiesis in the developing rainbow trout, Salmo gairdneri irideus: histochemical and immunochemical detection of erythropoietic organs. J. Exp. Zool. 1983, 226:409-417.
45. Javed A., Bae J.S., Afzal F., Gutierrez S., Pratap J., Zaidi S.K., Lou Y., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Structural coupling of smad and runx2 for execution of the BMP2 osteogenic signal. J. Biol. Chem. 2008, 283:8412-8422.
46. Johnson L.R., Byrne J.H. Essential Medical Physiology 2003, Third ed.
47. Jämsä T., Viluksela M., Tuomisto J.T., Tuomisto J., Tuukkanen J. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on bone in two rat strains with different aryl hydrocarbon receptor structures. J. Bone. Miner. Res. 2001, 16:1812-1820.
48. Keller J.M., Kucklick J.R., Stamper M.A., Harms C.A., McClellan-Green P.D. Associations between organochlorine contaminant concentrations and clinical health parameters in loggerhead sea turtles from North Carolina, USA. Environ. Health Perspect. 2004, 112:1074-1079.
49. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
50. Lawton R.W., Ross M.R., Feingold J., Brown J.F. Effects of Pcb exposure on biochemical and hematological findings in capacitor workers. Environ. Health Perspect. 1985, 60:165-184.
51. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., Wozney J.M., Kim E.G., Choi J.Y., Ryoo H.M., Bae S.C. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 2000, 20:8783-8792.
52. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell. Biol. 1997, 17:2336-2346.
53. Lundstrom J., Borjeson H., Norrgren L. Histopathological studies of yolk-sac fry of Baltic salmon (Salmo salar) with the M74 syndrome. Ambio 1999, 28:16-23.
54. Maes, C., Carmeliet, G., 2008. Vascular and nonvascular roles of VEGF in bone development. Mol. Biol. Intellig. Unit, pp. 79-90.
55. Majeska R.J., Ryaby J.T., Einhorn T.A. Direct modulation of osteoblastic activity with estrogen. J. Bone Joint. Surg. Am. 1994, 76:713-721.
56. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett. 2006, 580:2811-2820.
57. Mcconnell E.E. Comparative toxicity of Pcbs and related-compounds in various species of animals. Environ. Health Perspect. 1985, 60:29-33.
58. Menuet A., Le Page Y., Torres O., Kern L., Kah O., Pakdel F. Analysis of the estrogen regulation of the zebrafish estrogen receptor (ER) reveals distinct effects of ERα, ERβ1 and ERβ2. J. Mol. Endocrinol. 2004, 32:975-986.
59. Miettinen H.M., Pulkkinen P., Jämsä T., Koistinen J., Simanainen U., Tuomisto J., Tuukkanen J., Viluksela M. Effects of in utero and lactational TCDD exposure on bone development in differentially sensitive rat lines. J. Toxicol. Sci. 2005, 85:1003-1012.
60. Mortensen A.S., Arukwe A. Targeted salmon gene array (SalArray): a toxicogenomic tool for gene expression profiling of interactions between estrogen and aryl hydrocarbon receptor signalling pathways. Chem. Res. Toxicol. 2007, 20:474-488.
61. Mortensen A.S., Arukwe A. Activation of estrogen receptor signaling by the dioxin-like aryl hydrocarbon receptor agonist, 3,3',4,4',5-pentachlorobiphenyl (PCB126) in salmon in vitro system. Toxicol. Appl. Pharmacol. 2008, 227:313-324.
62. Nijweide P.J., Burger E.H., Feyen J.H. Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol. Rev. 1986, 66:855-886.
63. Nikinmaa M., Rees B.B. Oxygen-dependent gene expression in fishes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:1079-1090.
64. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 2001, 81:1535-1565.
65. Norrgren L., Andersson T., Bergqvist P.A., Bjorklund I. Chemical, physiological and morphological-studies of feral Baltic salmon (Salmo salar) suffering from abnormal fry mortality. Environ. Toxicol. Chem. 1993, 12:2065-2075.
66. Ohtake F., Takeyama K., Matsumoto T., Kitagawa H., Yamamoto Y., Nohara K., Tohyama C., Krust A., Mimura J., Chambon P., Yanagisawa J., Fujii-Kuriyama Y., Kato S. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003, 423:545-550.
67. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
68. Owen T.A., Aronow M.S., Barone L.M., Bettencourt B., Stein G.S., Lian J.B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991, 128:1496-1504.
69. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
70. Pollenz R.S., Davarinos N.A., Shearer T.P. Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. Mol. Pharmacol. 1999, 56:1127-1137.
71. Puga A., Tomlinson C.R., Xia Y. Ah receptor signals cross-talk with multiple developmental pathways. Biochem. Pharmacol. 2005, 69:199-207.
72. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 2003, 9:677-684.
73. Rani P.U., Stringa E., Dharmavaram R., Chatterjee D., Tuan R.S., Khillan J.S. Restoration of normal bone development by human homologue of collagen type II (COL2A1) gene in Col2a1 null mice. Dev. Dyn. 1999, 214:26-33.
74. Reddi A.H. Regulation of local differentiation of cartilage and bone by extracellular matrix: a cascade type mechanism. Prog. Clin. Biol. Res. 1982, 110:261-268.
75. Reddi A.H. Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr. Opin. Cell Biol. 1992, 4:850-855.
76. Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology 2004, 19:176-182.
77. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 1992, 12:5447-5454.
78. Shi X., Liu C., Wu G., Zhou B. Waterborne exposure to PFOS causes disruption of the hypothalamus-pituitary-thyroid axis in zebrafish larvae. Chemosphere 2009, 77:1010-1018.
79. Siegel P.M., Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 2003, 3:807-821.
80. Singh S., Casper R., Fritz P., Sukhu B., Ganss B., Girard B., Savouret J., Tenenbaum H. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J. Endocrinol. 2000, 167:183-195.
81. Stevens D.A., Williams G.R. Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol. Cell. Endocrinol. 1999, 151:195-204.
82. Suzuki Y., Montagne K., Nishihara A., Watabe T., Miyazono K. BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. J. Biochem. 2008, 143:199-206.
83. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
84. Teitelbaum S.L., Tondravi M.M., Ross F.P. Osteoclasts, macrophages, and the molecular mechanisms of bone resorption. J. Leukoc. Biol. 1997, 61:381-388.
85. Vaes B.L., Ducy P., Sijbers A.M., Hendriks J.M., van Someren E.P., de Jong N.G., van den Heuvel E.R., Olijve W., van Zoelen E.J., Dechering K.J. Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation. Bone 2006, 39:724-738.
86. Villeneuve D.L., Curtis L.R., Jenkins J.J., Warner K.E., Tilton F., Kent M.L., Watral V.G., Cunningham M.E., Markle D.F., Sethajintanin D., Krissanakriangkrai O., Johnson E.R., Grove R., Anderson K.A. Environmental stresses and skeletal deformities in fish from the Willamette River, Oregon. Environ. Sci. Technol. 2005, 39:3495-3506.
87. Vuorinen P.J., Paasivirta J., Keinanen M., Koistinen J., Rantio T., Hyotylainen T., Welling L. The M74 syndrome of Baltic salmon (Salmo salar) and organochlorine concentrations in the muscle of female salmon. Chemosphere 1997, 34:1151-1166.
88. Wan C., Shao J., Gilbert S.R., Riddle R.C., Long F., Johnson R.S., Schipani E., Clemens T.L. Role of HIF-1α in skeletal development. Ann. N.Y. Acad. Sci. 2010, 1192:322-326.
89. Weiss J.M., Andersson P.L., Lamoree M.H., Leonards P.E., van Leeuwen S.P., Hamers T. Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol. Sci. 2009, 109:206-216.
90. Widmayer E.P., Raff H., Strang K.T. Vander's Human Physiology: The Mechanism of Body Functions 2006, Tenth ed.
91. Wuelling M., Kaiser F.J., Buelens L.A., Braunholz D., Shivdasani R.A., Depping R., Vortkamp A. Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with the activator form of Gli3. Dev. Biol. 2009, 328:40-53.
92. Wuelling M., Vortkamp A. Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification. Pediatr. Nephrol. 2010, 25:625-631.
93. Xiao Z., Awad H.A., Liu S., Mahlios J., Zhang S., Guilak F., Mayo M.S., Quarles L.D. Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice. Dev. Biol. 2005, 283:345-356.
94. Yang Y. Skeletal morphogenesis during embryonic development. Crit. Rev. Eukaryot. Gene Expr. 2009, 19:197-218.
95. Zhou G., Zheng Q., Engin F., Munivez E., Chen Y., Sebald E., Krakow D., Lee B. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:19004-19009.